News

Pharmabiz39m

RDCA seeks Delhi CM’s intervention to revoke two recent directives that cause economic hardships to traders

Peethambaran Kunnathoor, Chennai Friday, August 22, 2025, 08:00 Hrs [IST] ...
Pharmabiz39m

Removing or reducing GST would immediately ease financial load on senior health cover: Gaurav Dubey

Removing or reducing GST would immediately ease financial load on senior health cover: Gaurav Dubey: Nandita Vijayasimha, Bengaluru Friday, August 22, 2025, 08:00 Hrs [IST] Prime ...
Pharmabiz39m

PCI releases draft curriculum for B Pharm course integrating new age technologies, emerging domains

PCI releases draft curriculum for B Pharm course integrating new age technologies, emerging domains: Gireesh Babu, New Delhi Friday, August 22, 2025, 08:00 Hrs [IST] The Pharmacy ...
Pharmabiz39m

DoC, Pharmexcil discuss localization trends, concerns related to online CoPP during trade performance review

DoC, Pharmexcil discuss localization trends, concerns related to online CoPP during trade performance review: Shardul Nautiyal, Mumbai Friday, August 22, 2025, 08:00 Hrs [IST] The ...
Pharmabiz39m

Pharmexcil organises session on "India-Romania Pharma Business Opportunities” to boost exports

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) in association with Embassy of India at Romania recently organized a session on "India-Romania Pharma Business Opportunities” and B2B ...
Pharmabiz39m

Parliamentary Panel asks DoP to address issues related to implementation of schemes

Parliamentary Panel asks DoP to address issues related to implementation of schemes: Gireesh Babu, New Delhi Friday, August 22, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Un ...
Pharmabiz14h

Myosin Therapeutics awarded $4.5 million NCI Bridge Grant to advance phase I trial of MT-125 in glioblastoma

Myosin Therapeutics awarded $4.5 million NCI Bridge Grant to advance phase I trial of MT-125 in glioblastoma: Jupiter, Florida Thursday, August 21, 2025, 18:00 Hrs [IST] Myosin Th ...
Pharmabiz15h

ARC Therapies advances gut microbiome research with YB328 toward clinical application

ARC Therapies advances gut microbiome research with YB328 toward clinical application: Tokyo Thursday, August 21, 2025, 17:00 Hrs [IST] ARC Therapies Inc with head office at Shinj ...
Pharmabiz16h

US FDA grants fast track designation to Altimmune’s pemvidutide to treat alcohol use disorder

US FDA grants fast track designation to Altimmune’s pemvidutide to treat alcohol use disorder: Gaithersburg, Maryland Thursday, August 21, 2025, 16:00 Hrs [IST] Altimmune, Inc., ...
Pharmabiz16h

Thermo Fisher Scientific announces crucial investments in India at Biopharma Conclave 2025

Thermo Fisher Scientific announces crucial investments in India at Biopharma Conclave 2025: Our Bureau, Bengaluru Thursday, August 21, 2025, 15:45 Hrs [IST] Thermo Fisher Scientif ...
Pharmabiz17h

Qure.ai expands executive team with Dr Javier J Zulueta chief medical officer, pulmonology to bolster cancer survival

Qure.ai expands executive team with Dr Javier J Zulueta chief medical officer, pulmonology to bolster cancer survival: Our ...
Pharmabiz17h

Anvayaa strengthens focus on healthcare and well-being for senior citizens

Anvayaa strengthens focus on healthcare and well-being for senior citizens: Our Bureau, Bengaluru Thursday, August 21, 2025, 15:15 Hrs [IST] Anvayya, a 360-degree, tech-enabled se ...